Wells Fargo gets a bold upgrade ahead of earnings. Why the stock can play catch-up

Morgan Stanley upgraded Wells Fargo to a buy-equivalent rating and named it a top pick, setting a $102 price target that implies about 27% upside from Friday’s close, ahead of earnings next Tuesday. The analysts expect NIM to stabilize around 2.42% through Q1 2027 and reach 2.49% by Q4 2027, while projecting return on tangible common equity to rise from 15.5% in 2026 to 17% in the second half of 2027 and 18% in 2028. They also see potential for roughly $4 billion in additional annual investment-banking fees as Wells expands its fee businesses; shares rose about 1.5% Monday but remain down about 12% this year.

Analysis

The key question is whether WFC can convert balance-sheet capacity into higher returns without continuing to buy growth with costly funding. If wholesale funding needs recede as asset growth normalizes, incremental NIM improvement could lift earnings quality and support a rerating; if deposit gathering fails to keep pace, the growth itself remains a margin drag. The next earnings report is an unusually near-term test of that funding mix, not proof that the 2027 profitability path is secured.

The fee opportunity is strategically attractive but slower and less certain than the NIM thesis. Hiring senior bankers builds capacity, not transactions: M&A and capital-markets fees remain exposed to deal cycles, and share gains must be sustained before investors capitalize a larger run-rate. A stronger WFC could also compete for corporate relationships and mandates, but the article provides no evidence yet of material displacement at established leaders such as Goldman Sachs.

Contrarian read: the low forward multiple may reflect execution and timing risk rather than a missed, near-term earnings inflection. A favorable rate move is not automatically a tailwind if deposit costs reprice upward or asset yields reset faster. Near term, earnings guidance and funding mix matter more than the analyst target; over 6–18 months, durable fee growth and returns on capital determine whether the discount closes.

Key Decisions for Investors

• Consider a staged long in WFC, with the first tranche only if the upcoming report shows NIM stabilizing and reduced reliance on wholesale funding; add on evidence of follow-through rather than on the upgrade alone. The setup offers rerating potential, but execution risk argues against treating the full projected upside as a base case.
• Use earnings as the near-term thesis checkpoint: verify deposit growth and costs, wholesale funding levels, NIM outlook, and fee revenue. If funding costs remain elevated or management guides to further margin pressure, defer additions and reassess the profitability timeline.
• Treat investment-banking upside as a 6–18 month watch item, not a current earnings assumption. Track fee growth and evidence of repeat mandates; senior hiring without sustained deal wins would falsify the fee-convergence case.
• No forced peer short: Goldman Sachs has a distinct, established fee franchise, so WFC’s potential gains do not by themselves justify shorting GS. Revisit relative value only if WFC demonstrates durable fee share gains while its valuation discount remains wide.